At The Lovett Center, we are dedicated to helping individuals and families understand their options for safe, effective treatment. Many people searching for “belbuca vs suboxone” want clear answers about how these medications differ and what each is used for. Our team uses evidence-based practices and provides clear information to help people make informed choices.
The main difference between Suboxone and Belbuca is their purpose and how they are used. Suboxone is used to treat opioid addiction, while Belbuca is used to manage chronic pain. Both medications contain buprenorphine, but they are not the same and are not interchangeable. Understanding the details of each can help people work with their care provider to find the right treatment plan.
What is Belbuca?
Key facts about Belbuca:
- Primary use: Chronic pain management requiring around-the-clock treatment
- Form: Buccal film (placed inside cheek)
- Active ingredient: Buprenorphine only
- Dosing frequency: Every 12 hours
Belbuca is a prescription medication used to manage chronic pain that requires continuous, around-the-clock treatment. It comes as a buccal film, which means it is a thin strip placed against the inside of the cheek, not under the tongue. The film slowly dissolves so the active ingredient can be absorbed into the bloodstream.
The main ingredient in Belbuca is buprenorphine. Buprenorphine is a type of medicine called a partial opioid agonist. This means it attaches to the same brain receptors as stronger opioids but activates them less fully, which can help relieve pain with a lower risk of causing a “high” or severe side effects.
Belbuca is not used for opioid addiction treatment. It is approved only for managing ongoing pain in people who need long-term opioid therapy and have not found relief with other pain medicines.
Belbuca contains buprenorphine, which is classified as an opioid because it acts on opioid receptors in the body. However, as a partial agonist, its effects are milder than full opioids like morphine or oxycodone.
What is Suboxone?
Key points about Suboxone:
- Primary use: Opioid use disorder (OUD) treatment
- Form: Sublingual film or tablet (under tongue)
- Active ingredients: Buprenorphine + naloxone
- Dosing frequency: Usually once daily
Suboxone is a prescription medication used to treat opioid use disorder (OUD). It’s often part of a MAT program in Houston, Texas, which combines medication with counseling and supportive services.
Suboxone contains two active ingredients: buprenorphine and naloxone. Buprenorphine is a partial opioid agonist, which means it attaches to opioid receptors in the brain and activates them less strongly than full opioids. Naloxone is an opioid antagonist, which means it blocks opioid receptors and is used to help prevent misuse of the medication.
Buprenorphine and Suboxone are not the same. Buprenorphine is the name of the medication that can be prescribed on its own, while Suboxone is a brand name for the combination of buprenorphine and naloxone. The presence of naloxone in Suboxone is what makes it different from buprenorphine alone.
Is Belbuca the Same as Suboxone?
No, Belbuca and Suboxone are not the same. Both medications contain buprenorphine, but they are made for different purposes, have different ingredients, and are approved by the FDA for different uses.
Belbuca is made with buprenorphine as the only active ingredient. It is a buccal film, which means it is placed inside the cheek, and it is approved by the FDA for managing chronic pain that requires ongoing, around-the-clock opioid therapy.
Suboxone contains two active ingredients: buprenorphine and naloxone. It comes as a film or tablet that is placed under the tongue (sublingual). Suboxone is approved by the FDA for treating opioid use disorder.
Belbuca and Suboxone are not interchangeable, even though both contain buprenorphine. They are prescribed for different reasons and work in different ways in the body.Formulation and ingredients
Belbuca contains only buprenorphine as its active ingredient. Suboxone contains both buprenorphine and naloxone. The naloxone in Suboxone is included to help prevent the medication from being misused by injection, as naloxone can cause withdrawal symptoms if injected but remains inactive when taken as prescribed.
Side Effects of Belbuca vs Suboxone
Belbuca and Suboxone can cause side effects because they both contain buprenorphine, which acts on opioid receptors in the body. The type and intensity of side effects may vary based on the dose, individual health factors, and other medications being taken.
Common Side Effects
Belbuca and Suboxone share many of the same common side effects. These may include:
- Nausea or vomiting
- Constipation
- Dizziness or drowsiness
- Headache
- Fatigue or tiredness
- Sweating
- Dry mouth
- Sleep problems
- Redness or irritation in the mouth (where the film or tablet is placed)
Most common side effects are mild to moderate in intensity and often improve over time or with dose adjustments.
Serious Risks and Warnings
There are also serious risks associated with both medications:
- Respiratory depression: Both medications can slow breathing, especially when used with other central nervous system depressants such as alcohol or benzodiazepines. Respiratory depression is a potentially life-threatening condition.
- Severe allergic reactions: Rare, but may include swelling, rash, or difficulty breathing.
- Drug interactions: Combining Belbuca or Suboxone with other medications that affect the brain or breathing, known as polysubstance abuse, increases the risk of dangerous side effects.
- Withdrawal symptoms: Stopping either medication suddenly can lead to withdrawal symptoms such as muscle aches, sweating, anxiety, and insomnia. Taking Suboxone or Belbuca while other opioids are still in the system can cause sudden withdrawal.
- Dependence and misuse: Both medications carry a risk of dependence and misuse, especially in people with a history of substance use disorder.
Which Medication Treats Chronic Pain vs Opioid Addiction
Belbuca is prescribed for the treatment of chronic pain that is severe enough to require daily, long-term opioid therapy when other pain treatments are not effective. It works by delivering buprenorphine in a steady, controlled way through a film placed inside the cheek. For people living with persistent pain, Belbuca can provide consistent symptom relief without the rapid highs and lows associated with stronger opioids. Whether Belbuca is considered a “strong pain killer” depends on a person’s pain condition and previous opioid use; it is less potent than full opioid agonists like morphine or oxycodone, but can be effective for many chronic pain cases.
Suboxone is not typically used for pain management. Its main purpose is to treat opioid use disorder (OUD) by reducing withdrawal symptoms and cravings in people who are trying to stop using other opioids. Suboxone contains both buprenorphine and naloxone, and its dosing and formulation are designed for addiction treatment, not pain relief. While buprenorphine has pain-relieving properties, the dose and delivery in Suboxone are not tailored for chronic pain control.
Abuse Potential and Safety Concerns
Both Belbuca and Suboxone contain buprenorphine and are classified as controlled substances due to their potential for misuse. Misuse means taking the medication in a way not prescribed, such as taking higher doses, using it without a prescription, or trying to inject or snort it.
Belbuca is made of buprenorphine only and does not contain a deterrent for misuse. This means Belbuca can be misused, especially if someone tries to inject it. Misuse of Belbuca can lead to a “belbuca high,” which is when the medication produces feelings of euphoria. This is more likely to occur in people who do not have a tolerance to opioids or in those who take more than prescribed, which could pave the way toward the most addictive drugs. The risk of misuse is a key safety concern for Belbuca, especially in those with a history of substance use disorder.
Suboxone contains both buprenorphine and naloxone. The naloxone is added to reduce the risk of misuse by injection. If Suboxone is injected, naloxone can block the effects of buprenorphine and cause withdrawal symptoms instead of euphoria. This makes Suboxone less likely to be misused for a high compared to buprenorphine-only products like Belbuca.
According to the National Institute on Drug Abuse (NIDA), in 2022 about 8.7 million people in the United States misused prescription pain relievers in the past year. Prescription opioid misuse increases the risk for overdose, dependence, and serious health problems. Both Belbuca and Suboxone are monitored medications, and safe use involves regular check-ins with a healthcare provider.
Both medications have risks if used with other substances, especially other sedatives like benzodiazepines or alcohol, as this can increase the chance of respiratory depression and overdose. Using either medication exactly as prescribed and only under medical supervision reduces safety concerns and helps prevent misuse.
Frequently Asked Questions About Belbuca and Suboxone
Belbuca buccal films usually dissolve completely in about 30 minutes when placed inside the cheek; they are not meant to be chewed or swallowed.
Belbuca and Suboxone are not meant to be taken together unless specifically directed by a healthcare provider because using both can raise the risk of overdose and they are prescribed for different conditions.
Belbuca is an opioid medication because it contains buprenorphine, a partial opioid agonist; “opioid” refers to both natural and synthetic substances that act on opioid receptors, while “opiate” refers only to drugs derived directly from the opium poppy.
If a dose is missed, it is generally taken as soon as remembered unless it is almost time for the next dose; always follow the instructions given by the prescribing clinician.
Both Belbuca and Suboxone can cause a positive result for buprenorphine on drug tests, and special tests may be required to distinguish buprenorphine from other opioids.
Finding the Right Treatment Path for Your Needs
The Lovett Center provides support for individuals managing chronic pain, opioid use disorder, or co-occurring conditions. Treatment planning involves careful assessment of medical history, current symptoms, and personal goals. Clinicians at The Lovett Center use evidence-based therapies, including medication management, individual counseling, and group support, to address the needs of each person.
Chronic pain and substance use challenges often overlap, and treatment approaches are tailored accordingly. Suboxone and Belbuca are prescribed based on specific diagnoses and clinical guidelines rather than patient preference. The Lovett Center’s staff coordinates care with prescribing healthcare professionals, ensuring medication decisions align with broader mental health and recovery plans.
Personalized care plans may include trauma-informed therapy, cognitive-behavioral techniques, and ongoing monitoring. Families and support systems are included when appropriate to strengthen recovery and promote stability. The Lovett Center aims to provide a safe environment for exploring options and making informed decisions about medication and therapy.
To learn more about available treatment programs or to start a confidential assessment, contact The Lovett Center.
Robert is deeply committed to serving others and is passionate about hope and despair in clinical treatment. With over 20 years in addiction and mental health, he has experience in private practice, clinical supervision, and program management, co-founding The Lovett Center and Ethos. He earned a Master’s degree from the University of Houston’s Graduate College of Social Work, which honored him as a 50 for 50 Alumni in 2019. His education includes fellowships at the Center for Psychoanalytic Studies and The Menninger Clinic, where he held leadership roles and received the Menninger Clinic Pillar Award for Integrity. The Houston Business Journal recognized him as a 40 Under 40 Class of 2018 Honoree.
